• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[绿色荧光蛋白在体外和体内柯蒂氏器中非病毒转染的表达模式。非病毒载体对内耳的基因治疗]

[Expression patterns of non-viral transfection with GFP in the organ of Corti in vitro and in vivo. Gene therapy of the inner ear with non-viral vectors].

作者信息

Praetorius M, Pfannenstiel S, Klingmann C, Baumann I, Plinkert P K, Staecker H

机构信息

Sektion Otologie und Neuro-Otologie, Hals-, Nasen-, Ohrenklinik mit Poliklinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg.

出版信息

HNO. 2008 May;56(5):524-9. doi: 10.1007/s00106-008-1738-6.

DOI:10.1007/s00106-008-1738-6
PMID:18409074
Abstract

BACKGROUND

Diseases of the inner ear such as presbycusis, tinnitus, sudden hearing loss, and vertigo affect many patients, but so far there are no specific therapy options. Gene therapy might become a potential modality of treatment. Viral vectors are standard in animal models to date. Future considerations, however, call for a further evaluation of non-viral transfection methods.

MATERIAL AND METHODS

The non-viral transfection agents Metafectene, Superfect, Effectene, and Mirus TransIT were incubated with a plasmid coding for GFP. In vivo, the plasmid-agent mix was injected via the membrane of the round window, and 48 h later the inner ear was perfused, harvested, decalcified, and histologically evaluated for GFP expression.

RESULTS

Cationic lipids (Metafectene) and dendrimers (Superfect) were able to transfect cells in the area of the organ of Corti and lead to GFP expression. The polyamine (Mirus TransIT) did show expression of GFP in the area of Rosenthal's canal and in the area of the inner hair cell. The combination of a non-liposomal lipid with a DNA condensing component (Effectene) did not show transfection of the organ of Corti. In the area of the spiral ganglia cells, GFP expression was seen with all the transfection agents.

CONCLUSIONS

Non-viral transfection agents are able to introduce a reporter gene in cells of the inner ear in vitro and in vivo. There are, however, differences in the efficiency of the transfection. They might be an alternative in gene therapy of the inner ear. Further investigations to elucidate their potential are needed.

摘要

背景

诸如老年性聋、耳鸣、突发性听力损失和眩晕等内耳疾病影响着众多患者,但迄今为止尚无特异性治疗方案。基因治疗可能成为一种潜在的治疗方式。病毒载体是目前动物模型中的标准方法。然而,未来的考量要求进一步评估非病毒转染方法。

材料与方法

将非病毒转染试剂Metafectene、Superfect、Effectene和Mirus TransIT与编码绿色荧光蛋白(GFP)的质粒一起孵育。在体内,将质粒 - 试剂混合物经圆窗膜注射,48小时后对内耳进行灌注、取材、脱钙,并进行组织学评估以检测GFP表达。

结果

阳离子脂质(Metafectene)和树枝状聚合物(Superfect)能够转染柯蒂氏器区域的细胞并导致GFP表达。多胺(Mirus TransIT)在螺旋神经节管区域和内毛细胞区域确实显示出GFP表达。非脂质体脂质与DNA凝聚成分的组合(Effectene)未显示柯蒂氏器的转染。在螺旋神经节细胞区域,所有转染试剂均可见GFP表达。

结论

非病毒转染试剂能够在体外和体内将报告基因导入内耳细胞。然而,转染效率存在差异。它们可能是内耳基因治疗的一种替代方法。需要进一步研究以阐明其潜力。

相似文献

1
[Expression patterns of non-viral transfection with GFP in the organ of Corti in vitro and in vivo. Gene therapy of the inner ear with non-viral vectors].[绿色荧光蛋白在体外和体内柯蒂氏器中非病毒转染的表达模式。非病毒载体对内耳的基因治疗]
HNO. 2008 May;56(5):524-9. doi: 10.1007/s00106-008-1738-6.
2
Viral vector tropism for supporting cells in the developing murine cochlea.病毒载体对发育中的小鼠耳蜗支持细胞的亲嗜性。
Hear Res. 2011 Jul;277(1-2):28-36. doi: 10.1016/j.heares.2011.03.016. Epub 2011 Apr 22.
3
Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.脂质体介导的 RNA 传递比非分裂细胞中 DNA 的传递更有效。
Int J Pharm. 2010 Apr 15;389(1-2):232-43. doi: 10.1016/j.ijpharm.2010.01.019. Epub 2010 Jan 18.
4
Metafectene is superior to lipofectamine in the transfection of G(s) alpha prostate cancer cells.在对G(s)α前列腺癌细胞进行转染时,Metafectene比脂质体转染试剂更具优势。
Mol Biotechnol. 2004 Oct;28(2):97-103. doi: 10.1385/MB:28:2:097.
5
Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear.经鼓室递送达寡聚精氨酸缀合纳米颗粒作为内耳的基因(或药物)载体。
Biomaterials. 2015 Dec;73:243-53. doi: 10.1016/j.biomaterials.2015.09.025. Epub 2015 Sep 24.
6
Identification of Adeno-Associated Viral Vectors That Target Neonatal and Adult Mammalian Inner Ear Cell Subtypes.靶向新生和成年哺乳动物内耳细胞亚型的腺相关病毒载体的鉴定
Hum Gene Ther. 2016 Sep;27(9):687-99. doi: 10.1089/hum.2016.053. Epub 2016 Jun 24.
7
Helios(®) Gene Gun-Mediated Transfection of the Inner Ear Sensory Epithelium: Recent Updates.Helios(®)基因枪介导的内耳感觉上皮转染:最新进展
Methods Mol Biol. 2016;1427:3-26. doi: 10.1007/978-1-4939-3615-1_1.
8
Pyridinium cationic lipids in gene delivery: an in vitro and in vivo comparison of transfection efficiency versus a tetraalkylammonium congener.用于基因递送的吡啶鎓阳离子脂质:与四烷基铵同系物相比的体外和体内转染效率比较
Arch Biochem Biophys. 2005 Mar 1;435(1):217-26. doi: 10.1016/j.abb.2004.12.010.
9
Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells.超支化多聚赖氨酸纳米颗粒进入耳蜗细胞的核内。
Int J Nanomedicine. 2011;6:535-46. doi: 10.2147/IJN.S16973. Epub 2011 Mar 14.
10
Adenovirus Vectors Target Several Cell Subtypes of Mammalian Inner Ear .腺病毒载体靶向哺乳动物内耳的多种细胞亚型。
Neural Plast. 2016;2016:9409846. doi: 10.1155/2016/9409846. Epub 2016 Dec 28.

引用本文的文献

1
Application of Nanomedicine in Inner Ear Diseases.纳米医学在内耳疾病中的应用。
Front Bioeng Biotechnol. 2022 Feb 11;9:809443. doi: 10.3389/fbioe.2021.809443. eCollection 2021.
2
Emerging Gene Therapies for Genetic Hearing Loss.针对遗传性听力损失的新兴基因疗法。
J Assoc Res Otolaryngol. 2017 Oct;18(5):649-670. doi: 10.1007/s10162-017-0634-8. Epub 2017 Aug 16.
3
Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.用于治疗感音神经性听力损失的纳米基内耳给药系统的进展

本文引用的文献

1
Non-viral cancer gene therapy: beyond delivery.非病毒癌症基因治疗:超越递送
Gene Ther. 2006 May;13(9):739-40. doi: 10.1038/sj.gt.3302692.
2
Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA.通过静脉注射质粒DNA在实验动物中进行基因免疫以产生抗体。
Biotechniques. 2006 Feb;40(2):199-208. doi: 10.2144/000112088.
3
Local inner-ear drug delivery and pharmacokinetics.局部内耳给药与药代动力学。
Adv Drug Deliv Rev. 2017 Jan 1;108:2-12. doi: 10.1016/j.addr.2016.01.004. Epub 2016 Jan 12.
4
Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency.聚酰胺-胺树枝状大分子作为内耳基因递送载体:如何提高转染效率。
Exp Ther Med. 2011 Sep;2(5):777-781. doi: 10.3892/etm.2011.296. Epub 2011 Jun 27.
5
Issues, indications, and controversies regarding intratympanic steroid perfusion.关于鼓室内类固醇灌注的问题、适应证及争议
Curr Opin Otolaryngol Head Neck Surg. 2008 Oct;16(5):434-40. doi: 10.1097/MOO.0b013e32830ce796.
Drug Discov Today. 2005 Oct 1;10(19):1299-306. doi: 10.1016/S1359-6446(05)03574-9.
4
Hearing loss and tinnitus: 250 million people and a US$10 billion potential market.听力损失与耳鸣:2.5亿人以及一个规模达100亿美元的潜在市场。
Drug Discov Today. 2005 Oct 1;10(19):1263-5. doi: 10.1016/S1359-6446(05)03594-4.
5
Nonviral gene delivery: techniques and implications for molecular medicine.
Expert Rev Mol Med. 2003 Sep 3;5(22):1-15. doi: 10.1017/S1462399403006562.
6
Hearing preservation after inner ear gene therapy: the effect of vector and surgical approach.内耳基因治疗后的听力保留:载体和手术方法的影响。
ORL J Otorhinolaryngol Relat Spec. 2003 Jul-Aug;65(4):211-4. doi: 10.1159/000073117.
7
Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes.内体中的氯离子积累和肿胀增强了多胺-DNA复合物的DNA转移。
J Biol Chem. 2003 Nov 7;278(45):44826-31. doi: 10.1074/jbc.M308643200. Epub 2003 Aug 27.
8
Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells.非病毒载体介导的基因转移至多种人类细胞中的效率与安全性比较。
Biol Pharm Bull. 2002 Jul;25(7):891-7. doi: 10.1248/bpb.25.891.
9
Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation.
Bioconjug Chem. 2002 May-Jun;13(3):453-61. doi: 10.1021/bc010103m.
10
Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis.脂质体介导的哺乳动物细胞转染是通过胆固醇依赖的网格蛋白介导的内吞途径发生的。
J Biol Chem. 2002 May 17;277(20):18021-8. doi: 10.1074/jbc.M111257200. Epub 2002 Mar 1.